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Abstract
Objective:The revision of theDiagnostic and StatisticalManual ofMentalDisorders, 5th ed. (DSM-5) added a newdiagnosis
of disruptive mood dysregulation disorder (DMDD) to depressive disorders. This study examines the prevalence, co-
morbidity, and correlates of the new disorder, with a particular focus on its overlap with oppositional defiant disorder (ODD),
with which DMDD shares core symptoms.
Methods: Data were obtained from 597 youth 6–18 years of age who participated in a systematic assessment of symptoms
offered to all intakes at a community mental health center (sample accrued from July 2003 to March 2008). Assessment
included diagnostic, symptomatic, and functional measures. DMDD was diagnosed using a post-hoc definition from item-
level ratings on the Schedule for Affective Disorders and Schizophrenia for School-Age Children that closely matches the
DSM-5 definition. Caregivers rated youth on the Child Behavior Checklist.
Results: Approximately 31% of youth met the operational definition of DMDD, and 40% had Diagnostic and Statistical
Manual of Mental Disorders, 4th ed. (DSM-IV) diagnoses of ODD. Youth with DMDD almost always had ODD (odds ratio
[OR] = 53.84) and displayed higher rates of comorbidity with attention-deficit/hyperactivity disorder (ADHD) and conduct
disorder than youth without DMDD. Caregivers of youth with DMDD reported more symptoms of aggressive behavior, rule-
breaking, social problems, anxiety/depression, attention problems, and thought problems than all other youth without
DMDD. Compared with youth with ODD, youth with DMDD were not significantly different in terms of categorical or
dimensional approaches to comorbidity and impairment.
Conclusions: The new diagnosis of DMDD might be common in community mental health clinics. Youth with DMDD
displayed more severe symptoms and poorer functioning than youth without DMDD. However, DMDD almost entirely
overlaps with ODD and youth with DMDD were not significantly different than youth with ODD. These findings raise
concerns about the potentially confusing effects of using DMDD in clinical settings, particularly given that DSM-5 groups
DMDDwith depressive disorders, butODD remains a disruptive behavior disorder, potentially changing the decision-making
framework that clinicians use to select treatments.
Introduction
In the past two decades, the clinical diagnosis of pediatricbipolar disorder (PBD) increased dramatically, leading to con-
cerns of misdiagnosis (Blader and Carlson 2007; Moreno et al.
2007). Likely driving part of the increase in PBD diagnoses is that
some investigators conceptualized nonepisodic severe irritability
as a core feature of PBD (Biederman 1995; Leibenluft et al. 2003),
whereas other investigators maintained that PBD, like bipolar
disorder in adults, consists of episodes with changes in mood and
energy (Leibenluft et al. 2003; Youngstrom et al. 2008).
To reduce the rate of diagnosis of PBD and resulting exposure
to psychotropic medications (Leibenluft 2011), Diagnostic and
Statistical Manual of Mental Disorders, 5th ed. (DSM-5) added
disruptive mood dysregulation disorder (DMDD) to describe chil-
dren with chronic irritability (American Psychiatric Association
2013). However, the diagnosis of DMDD has proven to be con-
troversial (Parens and Johnston 2010; Axelson et al. 2011;
Stringaris 2011; Taylor 2011). Concerns about DMDD fall pri-
marily into two categories: 1) The lack of a robust empirical basis
for the definition (i.e., construct validity of the new diagnosis) and
2) potential iatrogenic consequences of adding a new diagnostic
category with unknown treatment parameters. The lack of a robust
definition might have contributed to only chance levels of agree-
ment for a youth being diagnosed with DMDD by outpatient cli-
nicians during the DSM-5 field trial (Regier et al. 2013). Guidance
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on differentiating DMDD from other disorders is needed. DMDD is
meant to provide a diagnostic home for children with severe,
chronic irritability who do not meet a ‘‘classic’’ definition of
bipolar disorder and who might be too severely disturbed to have
‘‘just oppositional defiant disorder [ODD].’’ Therefore, the purpose
of the current article is to address the construct validity of DMDD
by examining its clinical prevalence, comorbidity, and impairment
in a community mental health center.
Limited empirical evidence exists as to the epidemiological
prevalence of DMDD as well as to the base rate in different clinical
settings. Applying post-hoc diagnoses to three regional epidemio-
logical studies, Copeland and colleagues (2013) suggest an epide-
miological base rate between 0.8% and 3.3%. In a cohort enriched
for mood symptoms, 26% of youth met criteria for a post-hoc di-
agnosis of DMDD (Axelson et al. 2012). In a psychiatric inpatient
unit, 16–38% of youth met criteria for DMDD, depending upon the
exact operationalization of the criteria (Margulies et al. 2012). As
expected, the base rate increases as acuity of care increases, and is
quite variable depending upon the setting.
In addition to a clinical description of symptoms that can be
reliably diagnosed, a disorder should demonstrate: 1) Meaningful
differences in laboratory studies from other disorders, 2) longitu-
dinal course, and 3) different patterns of heritability; and 4) should
be different from other disorders( Robins and Guze 1970; Cantwell
1996). To date, there are no published studies examining pro-
spectively defined DMDD in terms of these criteria. Therefore,
clinical validity of the DMDD diagnosis might be inferred from
variations of the operational definition of severe mood dysregula-
tion (SMD), a substantially stricter research definition on which
DMDD was based. Compared with youth with bipolar disorder,
youth with SMD are less likely to have a family history of bipolar
disorder (Brotman et al. 2007), are less likely to demonstrate mania
episodes over brief follow-up periods (Stringaris et al. 2010), and
demonstrate differences on several neuropsychological domains
and measures of brain structure and functioning (Adleman et al.
2012). Over 2 and 4 year follow-up periods, most youth with SMD
continue to display clinically significant levels of irritability, but
less than half of youth continue to meet criteria for SMD (Deveney
et al. 2014). Taken together, these findings suggest that prospec-
tively defined SMD is different from bipolar disorder; however,
youth with SMD have not been differentiated from youth with other
more common disruptive behavior disorders.
Although prospective studies of DMDD are needed to diagnos-
tically and prognostically identify specific features of the disorder,
post-hoc examination of existing data sets can provide some infor-
mation regarding DMDD. Post-hoc diagnoses of DMDD and SMD
demonstrate very high levels of comorbidity with ODD, conduct
disorder, and attention-deficit/hyperactivity disorder (ADHD) in
both clinical research (Axelson et al. 2012) and epidemiological
settings (Brotman et al. 2006; Copeland et al. 2013). These findings
are similar to comorbidity patterns seen in prospectively defined
SMD in clinical settings (Rich et al. 2010). Additionally, data such as
parent-reported questionnaires of symptoms, suggest that youth with
DMDDare not different from youth with ODD (Axelson et al. 2012).
Therefore, youth with SMD and DMDD likely display a coherent
pattern of differences from youth with PBD. However, questions
remain about how distinct SMD is from DMDD and how distinct
SMD and DMDD are from ODD.
Despite the small but rapidly growing evidence base forDMDDas a
diagnosis, the extant available data show that youth with DMDD ap-
pear to be more functionally impaired than youth without DMDD
(Axelson et al. 2012; Copeland et al. 2013). A more thorough evalu-
ation of DMDD’s clinical prevalence, comorbidity, and impairment
would provide clinicians with guidance when considering giving a
youth the diagnosis. The current article adds to the existing literature
by examining a clinically relevant sample of youth presenting at a
general community mental health clinic, and examining the post-hoc
diagnosis of DMDD. The current article should add to the empirical
data about DMDD by examining the following:
1. How prevalent is DMDD in community mental health? In
relaxing the stricter research definition of SMD, does the
prevalence of DMDD increase?
2. Can DMDD be differentiated from other common disorders in a
community mental health clinic? What are the typical Diag-
nostic and Statistical Manual of Mental Disorders, 4th ed.
(DSM-IV) clinical diagnoses assigned to cases meeting criteria
for DMDD?Are some comorbid conditions so common, such as
ODD, as to challenge conceptualizations of DMDD as an in-
dependent diagnosis (American Psychiatric Association 1994)?
3. Does DMDD differ from other diagnoses in the severity of
presentation on established dimensions of emotion and be-
havior problems? Are the symptoms noted by different infor-
mants, such as the youth or teachers, as well as the caregiver?
4. How impairing is DMDD in a clinical sample relative to
other diagnoses?
Method
Participants
Participants (n=597) were recruited from all clinical intakes at a
large community mental health center (CMHC) in the Midwestern
United States using a consecutive case series design. Study inclusion
criteria were: 1) Being 5–18 years of age, 2) both caregiver and youth
providing written consent and assent, 3) both caregiver and youth
presenting for the assessment, and 4) both caregiver and youth con-
versant in English. Table 1displays the demographic characteristics of
the sample. Additional details of design and sample are available
(Youngstrom et al. 2005); the present article concentrates on the
community mental health clinic and not the academic medical center
subsample. Approximately 95% of youth served by the CMHC
qualified for Medicaid.
Measures
Diagnoses. The Kiddie Schedule for Affective Disorders and
Schizophrenia for School-Age Children (KSADS) is a semi-
structured interview that queries symptoms of common Axis I
disorders from both the caregiver and youth. The KSADS version
used combined the mood modules from the Washington University
KSADS (Geller et al. 2001) with the KSADS Present and Lifetime
version (Kaufman et al. 1997). Research assistants were highly
trained: Symptom level ratings for new raters were compared with
those from a reliable rater for at least five interviews rating along
and then five interviews leading. New research assistants passed a
session if they achieved an overall j‡0.85 at the symptom level of
the entire interview and a j = 1.0 at the diagnostic level. All
symptoms were queried, regardless of presenting problem. Re-
search assistants were trained to code mania and depressive
symptoms if they occurred in a definable episode. The KSADS
includes multiple places where irritability could be coded, because
it is a diagnostic symptom of multiple disorders. Raters coded ir-
ritability in the depression or mania module if it was 1) a change
from typical functioning and 2) occurred in the context of a distinct,
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episodic change of mood or energy. Raters coded irritability in
other modules if the irritability was more chronic and occurred in
the context of other symptoms of anxiety or disruptive behavior, or
if it was a reaction to a precipitant or traumatic event. Agreement
about these distinctions is captured in the j‡0.85 at the symptom
level. Interviews also provided the basis for the Children’s Global
Assessment Scale (CGAS) (Shaffer et al. 1983) and the Global
Family Environment Scale (GFES) (Rey et al. 1997) as overall
measures of functioning.
Child Behavior Checklist (CBCL). The CBCL (Achenbach
and Rescorla 2001) is among the most widely used measures of
child and adolescent behavior problems. The CBCL consists of 113
items that query about common emotional and behavioral problems
in youth between the ages of 6 and 18. Caregivers of youth age 5
completed the CBCL 1.5–5.5 years. Youth ages 12–18 (n = 199)
completed the 112 item Youth Self-Report Form (YSR). Teachers
completed the 113 item Teacher Report Form (TRF). All teachers
were mailed copies of the TRF and 33% (n= 195) returned the TRF.
T scores use nationally representative age and gender norms.
Young Mania Rating Scale (YMRS). The YMRS (Young
et al. 1978) is among the most widely used clinical measures for
grading severity of (hypo)mania. The YMRS consists of 11 items
querying about different symptoms of mania. Trained research
assistants rated each symptom; a = 0.85 in the present sample.
Table 1. Demographic Characteristics with a Focus on Disruptive Mood Dysregulation Disorder (DMDD)
Overall (n= 597) DMDD+ (n = 185) DMDD- (n = 412)
n (%) or Mean (SD) n (%) n (%)
Demographics
Gender, female 235 (39%) 65 (35%) 170 (41%)
Ethnicity
Non-White 559 (94%) 172 (93%) 387 (94%)
Age in years 10.58 (3.39) 10.40 (3.16) 10.66 (3.49)
Dimensional measures of psychopathology
Young Mania Rating Scale 6.01 (8.22) 5.43 (7.04) 6.28 (8.70)
Child Depression Rating Scale 29.82 (12.99) 29.44 (12.09) 29.99 (13.39)
Child Behavior Checklist
Anxious/Depressed 62.24 (9.75) 63.41 (9.76) 61.70 (9.71)
Withdrawn/Depressed 65.68 (11.03) 66.17 (11.29) 65.46 (10.91)
Somatic Complaints 59.46 (8.81) 59.96 (9.49) 59.24 (8.49)
Social Problems 65.62 (9.95) 67.86 (10.18) 64.59 (9.68)
Thought Problems 65.80 (9.98) 67.43 (10.00) 65.05 (9.90)
Attention Problems 70.04 (12.00) 72.17 (11.43) 69.08 (12.14)
Rule-Breaking Behavior 67.99 (8.32) 71.25 (7.23) 66.48 (8.37)
Aggressive Behavior 73.12 (12.56) 79.64 (10.57) 70.17 (12.29)
Internalizing 63.22 (10.43) 64.43 (10.11) 62.67 (10.53)
Externalizing 70.30 (9.74) 75.21 (6.64) 68.08 (10.10)
Total 69.14 (8.93) 72.40 (7.19) 67.67 (9.26)
Youth Self-Report Form (n= 299)
Anxious/Depressed 56.61 (9.01) 58.40 (9.51) 57.16 (9.19)
Withdrawn/Depressed 59.61 (9.94) 60.20 (9.42) 59.79 (9.77)
Somatic Complaints 58.32 (9.71) 59.48 (9.36) 58.68 (9.60)
Social Problems 57.82 (9.07) 60.71 (9.62) 58.71 (9.32)
Thought Problems 57.30 (8.82) 61.51 (10.16) 58.60 (9.44)
Attention Problems 58.59 (9.85) 61.32 (10.56) 59.43 (10.13)
Rule-Breaking Behavior 57.68 (8.28) 61.09 (8.08) 58.73 (8.35)
Aggressive Behavior 58.65 (10.09) 64.95 (10.83) 60.59 (10.71)
Internalizing 55.83 (12.60) 57.61 (12.53) 56.37 (12.58)
Externalizing 56.29 (11.96) 62.50 (11.45) 58.20 (12.13)
Total 56.49 (12.26) 61.21 (12.62) 57.94 (12.54)
Teacher Report Form (n= 195)
Anxious/Depressed 56.74 (7.72) 56.53 (6.70) 56.84 (8.19)
Withdrawn/Depressed 59.87 (9.36) 59.34 (7.94) 60.13 (10.00)
Somatic Complaints 55.91 (8.23) 55.94 (7.66) 55.89 (8.53)
Social Problems 61.51 (8.61) 62.95 (7.46) 60.80 (9.06)
Thought Problems 57.16 (8.57) 57.33 (8.26) 57.08 (8.74)
Attention Problems 65.52 (9.71) 65.88 (8.83) 63.69 (10.07)
Rule-Breaking Behavior 63.96 (8.64) 67.38 (9.06) 62.29 (7.94)
Aggressive Behavior 66.97 (12.00) 72.02 (12.51) 64.50 (10.97)
Internalizing 57.19 (10.46) 57.27 (9.12) 57.16 (11.08)
Externalizing 65.58 (10.63) 69.86 (10.64) 63.50 (10.01)
Total 64.81 (9.60) 67.16 (8.71) 63.66 (9.83)
Children’s Global Assessment Scale score (current) 52.73 (8.50) 50.51 (5.78) 53.73 (9.31)
Children’s Global Assessment Scale score (most severe past) 49.18 (9.07) 47.84 (6.60) 49.78 (9.94)
Family Environment Scale 67.37 (11.64) 66.15 (11.34) 67.92 (11.75)
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Child Depression Rating Scale-Revised (CDRS). The
CDRS ( Poznanski and Mokros 1996) is a clinician-rated measure
of depression symptoms. The CDRS consists of 17 items querying
about different symptoms of depression. Trained research assis-
tants rated each symptom; a= 0.91 in the present sample.
Retrospective DMDD and SMD diagnoses. Consistent
with prior post-hoc definitions of DMDD (Axelson et al. 2012;
Copeland et al. 2013) and SMD (Brotman et al. 2006), the fol-
lowing symptom criteria were used:
1. Severe recurrent temper outbursts. This criterion consisted
of the ‘‘loses temper’’ item at a threshold of ‘‘severe temper
outburst 2–5 times per week.’’
2. Chronic irritability. This criterion consisted of either the
‘‘easily annoyed or angered’’ or ‘‘angry or resentful’’ items
at a threshold of ‘‘daily or almost daily.’’
3. Duration. Participants who completed the ODD section of
the KSADS (i.e., all participants who met criteria 1 or 2 at
threshold) reported whether the symptoms were present for
the prior 6 months regardless of meeting criteria for ODD.
These duration criteria differ from the DMDD criterion E
(American Psychiatric Association 2013), which states that
symptoms must be present for at least 12 months without an
interval ‡3 months without symptoms.
4. Impairment in more than one setting. The ODD supplement
determined the presence of impairment caused by ODD
symptoms at home, with peers, and at school. Impairment had
to be rated at threshold in at least two settings (Criterion F).
5. Never have manic or hypomanic symptoms for ‡1 day.
DMDD criterion I excludes participants with episodic (hy-
po)manic symptoms lasting >1 day at a time, thus auto-
matically excluding youth with PBD. However, not all youth
display all symptoms of mania; therefore, this criterion
consisted of the ‘‘elated mood’’ symptom rated as ‘‘mild’’ or
greater, which is consistent with hypomania or greater se-
verity. Elated mood must be present for at least 4 hours.
6. Symptoms are not occurring exclusively during a psychotic
or mood disorder, nor are better accounted for by another
disorder (criterion J). Research assistants were trained to rate
symptoms only when the symptoms were not clearly ac-
counted for by another disorder (e.g., posttraumatic stress
disorder [PTSD], mood disorder, bipolar disorder).
7. Age at time of diagnosis (Criterion G) and age of onset
(Criterion H). These criteria were not coded because their
definition varies within DSM-5. Additionally, concerns re-
garding the accuracy of the age-related criteria exist (American
Psychiatric Association 2013).
The operational definition of SMD included these additional pa-
rameters:
8. Hyperarousal. SMD requires criteria 1–6 similar to DMDD and
also requires the presence of hyperarousal, which is defined as at
least two of the following: Distractibility, pressured speech, in-
trusiveness, or racing thoughts/flight of ideas. This criterion
consisted ofmatching symptom ratings at the threshold of ‘‘daily
or almost daily.’’
Procedure
The study was approved by the Institutional Review Boards
at Case Western Reserve University, Applewood Centers, and
the University of North Carolina at Chapel Hill. Highly
trained research assistants administered the KSADS to the
youth and the caregiver. Research assistants were primarily
predoctoral psychology interns or research staff. A licensed
clinical psychologist assigned final consensus diagnoses using
the Longitudinal Evaluation of All available Data procedure
(Spitzer 1983). Consensus diagnoses were masked to the
rating scales.
Analytic plan
Chi-squared tested associations between DMDD diagnostic
status and other categorical disorders. Multivariate analysis of
variance (MANOVA) tested for associations between DMDD and
dimensional measures of psychopathology (e.g., CBCL subscales).
Regression examined associations between DMDD and continuous
clinical variables (e.g., number of diagnoses). MANOVA and re-
gression were conducted two different ways. First, ODD and
DMDDwere operationalized hierarchically as defined in DSM-5 as
a single variable for comparison. Second, ODD and DMDD were
treated independently, and the interaction between ODD and
DMDD was included. In the second set of analyses, youth without
DMDD and ODD were compared with youth with only DMDD,
only ODD, and both ODD and DMDD. Kappa and odds ratios (OR)
provided effect sizes for categorical variables and Cohen’s d for
continuous variables. Alpha was 0.05.
Results
Aim 1. Prevalence of DMDD
Table 2 displays the diagnostic composition of the sample of
which 31% met criteria for DMDD. Only 27% (n = 160) of youth
met criteria for SMD. All youth who met criteria for SMD also met
criteria for DMDD; however, not all youth with DMD met criteria
for SMD, j = 0.90, p< 0.001.
Aim 2. Typical overlap of DSM-IV diagnoses
and DMDD
All youth meeting criteria for DMDD had at least one DSM-IV
diagnosis. Table 2 displays the patterns of diagnosis for youth
with and without DMDD. Youth with DMDD met criteria for
significantly more diagnoses than youth without DMDD (Cohen’s
d = 0.45). Compared with youth without DMDD, youth with
DMDD were more likely to have comorbid research diagnoses of
ODD (OR = 53.84, p < 0.001), conduct disorder (OR = 3.71,
p < 0.001), and ADHD (OR = 3.00, p < 0.001). Youth with DMDD
were less likely than youth without DMDD to have diagnoses of
bipolar I or II, OR = 0.09, p < 0.001. Comorbidity profiles for
youth with DMDD and without DMDD did not differ in terms of
cyclothymia/bipolar not otherwise specified (NOS), unipolar de-
pressive disorders, anxiety disorders, psychotic disorders, devel-
opmental disorders, and elimination disorders, ps > 0.05. Overall,
the pattern of comorbidity suggests that DMDD overlaps with
ODD almost entirely.
To determine the boundary between DMDD and ODD, a series
of logistic regressions compared the comorbidity profiles of
DMDD and ODD, treating each diagnosis independently by not
applying the hierarchical rule in DSM-5. Other Axis I diagnoses
were predicted by DMDD diagnosis, ODD diagnosis, and the in-
teraction between DMDD and ODD diagnoses. In all models, the
interaction step was not significant, all ps> 0.10. An additional
diagnosis or specifier of DMDD did not change the pattern of
overlap.
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Aim 3. Dimensional emotional and behavioral problem
scores for youth with DMDD
Table 1 displays the dimensional measures of psychopathology
for youth with and without DMDD. Compared with youth without
DMDD, MANOVA indicated that caregivers of youth with DMDD
reportedmore symptoms of aggressive behavior (Cohen’s d= 0.80),
rule-breaking (Cohen’s d= 0.59), social problems (Cohen’s
d = 0.33), anxious/depressed (Cohen’s d= 0.27), attention problems
(Cohen’s d = 0.26), and thought problems (Cohen’s d = 0.24), F(11,
537) = 12.44, p< 0.001. On measures of specific mood symptoms,
youth with DMDDwere not significantly different for symptoms of
mania (Cohen’s d= 0.10) or depression (Cohen’s d= 0.04) than
all other youth at the clinic. Youth with DMDD reported signifi-
cantly more severe aggressive behavior (Cohen’s d= 0.61), rule-
breaking (Cohen’s d= 0.42), thought problems (Cohen’s d= 0.41),
social problems (Cohen’s d = 0.31), and attention problems
(Cohen’s d = 0.27) than youth without DMDD, F(11, 287)= 3.22,
p < 0.001. According to teachers, youth with DMDD displayed
significantly more severe aggressive behavior (Cohen’s
d = 0.65) and rule-breaking (Cohen’s d = 0.61), F(11,183) = 2.65,
p < 0.01.
To determine the boundary between ODD and DMDD, two sets
of analyses were conducted. First, a MANOVA following the hi-
erarchical rules of DSM-5 compared youth with DMDDwith youth
with ODD. Youth with DMDD were not significantly different
from youth with ODD on caregiver reported symptoms F(11,
276) = 1.70, p= 0.07. Youth with DMDD were not significantly
different from youth with ODD in terms of current mania symp-
toms (Cohen’s d= 0.10) and depressive symptoms (Cohen’s
d = 0.24), ps > 0.10. Youth with DMDD were not significantly
different in self-reported symptoms on the YSR than youth without
DMDD, F(11, 148)= 1.34, p= 0.21. According to teacher report on
the TRF, youth with DMDDwere significantly different than youth
without DMDD, F(11, 93)= 2.46, p= 0.01. According to teacher
report, youth with DMDD were more aggressive than youth with-
out DMDD, F(1, 103)= 8.60, p< 0.01.
Second, a MANOVA was fit ignoring the hierarchical rule in-
cluded in DSM-5 so that youth without DMDD or ODD were
compared with youth with only ODD, only DMDD, and both
DMDD and ODD. The test of the interaction was not significant,
indicating that an additional specifier or diagnosis of DMDD in
addition to ODD did not cause caregivers to report significantly
more or less severe behavior, F(11, 535) = 1.76, p> 0.05. Ad-
ditionally, when examining clinician-rated mood symptoms in a
regression, the interaction step was not significant, D r2s< 0.01,
ps> 0.10. Similarly, the test of the interaction was not significant,
indicating no additional symptom severity above that of ODD for
youth with DMDD on the YSR – F(11, 285)= 1.27, p= 0.24 – and
TRF, F(11, 181) = 1.33, p= 0.21.
Impairment associated with DMDD
Youth with DMDDwere significantly more impaired than youth
without DMDD for both the current episode (Cohen’s d = 0.38) and
most severe past episode (Cohen’s d = 0.22). Additionally, youth
with DMDD trended toward having poorer family functioning than
youth without DMDD, d = 0.15. Compared with youth with ODD,
youth with DMDD were not significantly different in current im-
pairment (Cohen’s d = 0.12), most severe past functioning (Cohen’s
d= 0.07), or family environments (Cohen’s d = 0.12). Finally, re-
gression analyses indicated no significant interaction between
DMDD and ODD in predicting current impairment, past impair-
ment or family functioning, D r2s< 0.01, ps> 0.10.
Table 2. Research Diagnoses Associated with Disruptive Mood Dysregulation Disorder
Overall (n= 597) DMDD+ (n = 185) DMDD- (n= 412) Test statistic/Odds
ratio (95% CI) p Valuen (%) or Mean (SD) n (%) n (%)
More common among cases with DMDD
Number of diagnoses 2.62 (1.35) 3.03 (1.30) 2.44 (1.33) t = 5.02 <0.001*
Any disruptive behavior disorder 403 (68%) 179 (97%) 224 (54%) 25.04 (10.85–57.78) <0.001*
Oppositional defiant disorder 297 (50%) 177 (96%) 120 (29%) 53.84 (25.70–112.80) <0.001*
Conduct disorder 76 (13%) 44 (24%) 32 (8%) 3.71 (2.26–6.08) <0.001*
ADHD 388 (65%) 149 (81%) 239 (58%) 3.00 (1.98–4.53) <0.001*
No significant association with DMDD
Any mood disorder 247 (41%) 73 (39%) 174 (42%) 0.89 (0.63–1.27) 0.53
Any depressive disorder 171 (29%) 59 (32%) 112 (27%) 1.25 (0.86–1.83) 0.24
MDD 67 (11%) 20 (11%) 47 (11%) 0.94 (0.54–1.64) 0.82
Dysthymia 25 (4%) 9 (5%) 16 (4%) 1.26 (0.55–2.91) 0.58
Depressive disorder NOS 52 (9%) 22 (12%) 30 (7%) 1.71 (0.96–3.06) 0.07
Mood NOS 0 (0%) 0 (0%) 0 (0%) a 1.00
Any anxiety disorder 153 (26%) 46 (25%) 107 (26%) 0.94 (0.6–1.40) 0.76
Psychotic disorder 19 (3%) 6 (3%) 13 (3%) 1.03 (0.38–2.74) 0.96
Pervasive developmental disorder
or intellectual disability
12 (2%) 3 (2%) 9 (2%) 0.74 (0.20–2.75) 0.65
Elimination disorder 78 (13%) 28 (15%) 50 (12%) 1.29 (0.78–2.12) 0.32
Less common among cases with DMDD
Any bipolar spectrum disorder 77 (13%) 14 (8%) 63 (15%) 0.45 (0.25–0.83) 0.01*
Bipolar I/II 25 (4%) 1 (<1%) 24 (6%) 0.09 (0.01–0.65) <0.001*
Cyclothymia/bipolar NOS 52 (9%) 13 (7%) 39 (9%) 0.72 (0.38–1.39) 0.33
Percentages refer to percentage of column subsample; therefore, the denominator is 597 for overall, 185 for DMDD+, and 412 for DMDD-.
*p < .05.
aUnable to calculate a statistic.
ADHD, attention-deficit/hyperactivity disorder; MDD, major depressive disorder; NOS, not otherwise specified.
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Discussion
Irritability is the most common reason caregivers bring youth to
outpatient treatment (Yeh and Weisz 2001). Chronic, nonepisodic
irritability as defined by either the presence of ODD or DMDD was
common in an outpatient community mental health clinic. The
omission of the hyperarousal criterion from SMD in the DSM-5
definition of DMDD resulted in a higher prevalence of youth with
DMDD compared with youth with SMD. Similar to Deveney and
colleagues (2014), all youth who met criteria for SMD met criteria
for DMDD. However, not all youth with DMDD met criteria for
SMD, indicating that DMDD is broader and more inclusive than the
research diagnosis on which it was based. As is true for most dis-
orders, we found a substantially higher rate of DMDD than
community-based epidemiological studies (Copeland et al. 2013).
Our base rate for DMDDwas similar to that in an outpatient sample
enriched for mood symptoms (Axelson et al. 2012), but lower than
that in an inpatient unit (Margulies et al. 2012). Providers in
community mental health may expect *1 in 3 youth to meet cri-
teria for DMDD. Therefore, DMDD is likely to be one of the most
common disorders seen in youth treatment settings.
Present data show a coherent pattern of findings when comparing
youth who meet DMDD criteria with youth who do not. Similar to
all prior studies in both clinical samples (Brotman et al. 2007; Rich
et al. 2010; Axelson et al. 2012) and epidemiological samples
(Brotman et al. 2006; Copeland et al. 2013), youth with DMDD
were more likely to have a disruptive behavior disorder (DBD) (i.e.,
DBD-NOS, ODD, and conduct disorder) than a mood disorder. In
addition to a disruptive behavior disorder, research diagnoses in-
dicated that many youth with DMDD also had ADHD. Our findings
indicating extremely high overlap between DMDD and ODD were
consistent with all prior findings.
Consistent with the categorical diagnostic profile, the largest
effects observed in caregiver-reported symptoms were for aggres-
sive behavior, rule breaking, social problems, and attention prob-
lems. Additionally, both youth self-report and teacher report
indicated similarly large effects in aggressive behavior and rule
breaking. The profile in the dimensional results is more consistent
with that of youth with externalizing disorders than with that of
youth with internalizing disorders. Therefore, the pattern of overlap
for both the categorical and dimensional findings suggests that
DMDD manifests more like a disruptive behavior disorder than a
mood disorder, at least in cross-sectional data.
According to DSM-5, the diagnosis of DMDD should be re-
served for youth with severe irritability that manifests in multiple
settings and is impairing in at least one of them. In line with prior
findings (Axelson et al. 2012; Copeland et al. 2013), youth with
DMDD were more impaired than youth without DMDD. Youth
with DMDD trended toward having poorer family functioning than
youth without DMDD. In sum, youth with DMDD may represent a
subset of youth in the clinic having substantially more difficulties
than their treatment-seeking peers.
Is DMDD clinically or phenomenologically distinct from ODD?
DMDD was compared with ODD using two different approaches.
One set of analyses compared DMDD and ODD as hierarchically
defined in DSM-5 so that they could not be comorbid. The second
set of analyses relaxed the hierarchical exclusion. In both models,
DMDD was not significantly different than ODD in terms of di-
agnostic comorbidity, dimensional comorbidity, and impairment.
Therefore, the propensity toward nearly complete overlap with a
common, well-established disorder calls into question the distinc-
tiveness of DMDD. The much greater overlap with disruptive
behavior disorders than mood disorders and the dimensional
measures indicating externalizing difficulties for youth with
DMDD also challenges the DSM-5 including DMDD in the de-
pressive disorders chapter. Grouping DMDD with mood disorders
characterized by episodic presentation also seems conceptually
inconsistent. Mood disorders emphasize episodicity of symptoms,
whereas, DMDD emphasizes chronic, nonepisodic irritability and
mood dysregulation (American Psychiatric Association 2013;
Leibenluft et al. 2003).
The primary purpose of DSM-5 adding DMDDwas to reduce the
perceived overdiagnosis of PBD, and, therefore, to reduce exposure
to psychotropic medication (American Psychiatric Association
2013). Youth with DMDD were actually significantly less likely to
be diagnosed with bipolar I or II disorder. Additionally, if we had
excluded all youth from DMDD with definable (hypo)mania as
stipulated in DSM-5, then no youth receiving PBD diagnoses
would also meet DMDD criteria.
From our data, it is not known whether the use of the diagnosis of
DMDD would affect the intended change in prescription practices.
Polypharmacy and prescription of atypical antipsychotics are com-
mon among youth meeting criteria for research diagnoses of severe
DBD without comorbid bipolar disorder (Kowatch et al. 2013).
Additionally, trends in outpatient mental health visits indicate in-
creases in the use of polypharmacy and atypical antipsychotics,
particularly for youth with mood disorders (Olfson et al. 2006). If a
youth is diagnosed with DMDD, a DSM-5 mood disorder, and not
ODD, a DSM-5 disruptive behavior disorder, then clinical heuristics
imply that it might increase medication use. Therefore, it is a vital
empirical question for future services research to monitor actual
changes in treatment as diagnostic practices change.
Limitations
This sample reflects patients at a typical community mental
health clinic in an urban metropolitan area that has well-stratified
services for care (i.e., substance abuse and developmental disorders
are typically treated through separate settings). Generalizability to
other clinics would depend upon the similarity in presenting
problems and the extent to which DMDD is stable across race/
ethnicity. The rates for different disorders (Table 1) are helpful in
this regard. Despite the sample being drawn from a community
outpatient setting, our findings display consistency with epidemi-
ological studies as well as other clinical settings. However, the
sample is likely not representative of DMDD in settings that in-
clude higher functioning youth, such as schools. DMDD symptom
criteria were coded post-hoc from KSADS interviews, because
DMDD, or an interview for DMDD, did not exist at the time of data
collection. Future work should attempt to prospectively distinguish
DMDD from ODD. Despite this limitation, findings show re-
markable similarity to studies of youth diagnosed with SMD or
DMDD.
Conclusions
These post-hoc analyses found that youth meeting DMDD cri-
teria displayed substantial functional impairment with severe be-
havioral dysregulation. However, the utility of the diagnosis of
DMDD to everyday clinicians remains questionable, because dif-
ferentiation between DMDD and other common disorders (i.e.,
ODD) was minimal. Most youth who meet DMDD criteria also met
criteria for ODD. More importantly, DMDD did not distinguish
itself from ODD.
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Clinical Significance
Until a better evidence base exists, clinicians should be cautious
when diagnosing youth with DMDD, and treatment often might best
start with using evidence-based practices for ODD. Future research
needs to address both the utility of a different treatment approach as
well as elucidate a distinct etiology that might separate DMDD from
more commonly occurring disruptive behavior disorders.
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